202 related articles for article (PubMed ID: 44877)
1. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
Elizur A; Segal S; Yeret A; Ben-David M
Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
[No Abstract] [Full Text] [Related]
2. [The effect of propranolol, neuroleptics and their combination on serum prolactin levels of schizophrenic patients].
Elizur A; Segal Z; Yeret A; Aboo-Shach M; Ben-David M
Harefuah; 1979 Sep; 97(5-6):101-4. PubMed ID: 44254
[No Abstract] [Full Text] [Related]
3. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
Moritz S; Krausz M; Gottwalz E; Andresen B
Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
[TBL] [Abstract][Full Text] [Related]
4. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
Casey DE
Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
[No Abstract] [Full Text] [Related]
5. [A double-blind study of metoclopramide in the treatment of schizophrenia and determination of prolactin].
Gu SF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):328-30, 382. PubMed ID: 1304992
[TBL] [Abstract][Full Text] [Related]
6. Possible predictors of neuroleptic-resistant schizophrenic relapse: influence of negative symptoms and acute extrapyramidal side effects.
Kinon BJ; Kane JM; Chakos M; Munne R
Psychopharmacol Bull; 1993; 29(3):365-9. PubMed ID: 7907184
[TBL] [Abstract][Full Text] [Related]
7. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
Naber D; Ackenheil M; Laakmann G
Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
[TBL] [Abstract][Full Text] [Related]
8. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents].
Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G
Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377
[TBL] [Abstract][Full Text] [Related]
9. Medical and legal implications of side effects from neuroleptic drugs. A round-table discussion.
Cancro R; Davis JM; Klawans H; Tancredi L
J Clin Psychiatry; 1981 Feb; 42(2):78-82. PubMed ID: 6109720
[TBL] [Abstract][Full Text] [Related]
10. [Non-extrapyramidal motor side-effects in long-term therapy with neuroleptics: an analysis of 99 patients].
Ginzel I; Hilger E; Barnas C
Wien Klin Wochenschr; 2002 Jan; 114(1-2):38-43. PubMed ID: 12407934
[TBL] [Abstract][Full Text] [Related]
11. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
Gerlach J
J Clin Psychiatry; 1999; 60 Suppl 23():20-4. PubMed ID: 10625196
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of piquindone, a new atypical neuroleptic, in the treatment of the positive and negative symptoms of schizophrenia.
Cohen JD; Van Putten T; Marder S; Berger PA; Stahl SM
J Clin Psychopharmacol; 1987 Oct; 7(5):324-9. PubMed ID: 2890671
[TBL] [Abstract][Full Text] [Related]
13. Some adverse effects of antipsychotics: prevention and treatment.
Lader M
J Clin Psychiatry; 1999; 60 Suppl 12():18-21. PubMed ID: 10372605
[TBL] [Abstract][Full Text] [Related]
14. Choosing an atypical antipsychotic.
Sussman N
Int Clin Psychopharmacol; 2002 Aug; 17 Suppl 3():S29-33. PubMed ID: 12570069
[TBL] [Abstract][Full Text] [Related]
15. Prolactin and neuroleptic drugs.
Green AI; Brown WA
Endocrinol Metab Clin North Am; 1988 Mar; 17(1):213-23. PubMed ID: 2897910
[TBL] [Abstract][Full Text] [Related]
16. Addressing adverse effects of antipsychotic treatment in young patients with schizophrenia.
Correll CU
J Clin Psychiatry; 2011 Jan; 72(1):e01. PubMed ID: 21272508
[TBL] [Abstract][Full Text] [Related]
17. [Difficulties in neuroleptic treatment of schizophrenic patients].
Woggon B
Schweiz Arch Neurol Psychiatr (1985); 1985; 136(1):55-9. PubMed ID: 2579426
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of schizophrenia].
Houy-Durand E; Thibaut F
Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
20. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics.
Strejilevich SA; Palatnik A; Avila R; Bustin J; Cassone J; Figueroa S; Gimenez M; de Erausquin GA
Psychiatry Res; 2005 Feb; 133(2-3):277-80. PubMed ID: 15741003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]